Leprosy elimination—a virtual phenomenon or a reality?

BMJ

Volumn 324, Issue 7352, 2002, Pages 1516-

  Lockwood, Diana N J ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEPROSTATIC AGENT; PREDNISOLONE; STEROID;

EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; HUMAN; INFECTION CONTROL; INTERNATIONAL COOPERATION; LEPROSY; LEPROSY EPIDEMIOLOGY; MYCOBACTERIUM LEPRAE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; SHORT SURVEY; WORLD HEALTH ORGANIZATION;

EVIDENCE-BASED MEDICINE; HEALTH POLICY; HUMANS; INCIDENCE; INTERNATIONAL COOPERATION; LEPROSY; NERVOUS SYSTEM DISEASES; PREVALENCE; WORLD HEALTH;

EID: 0037157555     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.324.7352.1516     Document Type: Article

References (15)

1. WHO Expert Committee on Leprosy. Seventh report. World Health Organ Tech Rep Ser 1998; 874: 20.
2. World Health Assembly. Elimination of leprosy: resolution of the 44th World Health Assembly. Geneva: World Health Organization, 1991. (Resolution No WHA 44.9.)
3. Saunderson P, Gebre S, Desta K, Byass P, Lockwood DNJ. The pattern of leprosy-related neuropathy in the AMFES patients in Ethiopia: definitions, incidence, risk factors and outcome. Lepr Rev 2000; 71: 285–308.
4. Croft RP, Nicholls PG, Richardus JH, Smith WC. The treatment of acute nerve function impairment in leprosy: results from a prospective cohort study in Bangladesh. Lepr Rev 2000; 71: 154–168.
5. Lockwood DNJ. Steroids in leprosy type 1 (reversal) reactions: mechanisms of action and effectiveness. Lepr Rev 2000; 71(suppl):S111–S114.
6. Fine PE, Warndorff DK. Leprosy by the year 2000–what is being eliminated? Lepr Rev 1997; 68: 201–202.
7. Leprosy–global situation. Wkly Epidemiol Rec 2002; 77: 1–8. www.who.int/wer/77_1_26.html (accessed 13 Jun 2002).
8. Leprosy–global situation. Wkly Epidemiol Rec 1998; 73: 40. www.who.int/lep/disease/l2.htm (accessed 12 Jun 2002).
9. Leprosy–global situation. Wkly Epidemiol Rec 2000; 75: 225–232. www.who.int/wer/75_27_52.html (accessed 13 Jun 2002).
10. Girdhar BK, Girdhar A, Kumar A. Relapses in multibacillary leprosy patients: effect of length of therapy. Lep Rev 2000; 71: 144–153
11. World Health Organization. The final push strategy to eliminate leprosy as a public health problem: questions and answers. Geneva: WHO, 2002.
12. World Health Organization. Report on the third meeting of the WHO technical advisory group on elimination of leprosy. Geneva: WHO, 2002. (WHO/CDS/CPE/CEE/2002.29.)
13. Report of the International Leprosy Association Technical Forum 2002. Lep Rev, 2002 (in press).
14. Klatser PR, van Beers S, Madjid B, Day R, de Wit MY. Detection of Mycobacterium leprae nasal carriers in populations for which leprosy is endemic. J Clin Microbiol 1993; 31: 2947–2951.
15. Noordeen S. The epidemiology of leprosy. In: Leprosy. Hastings R, ed. Edinburgh: Churchill Livingstone, 1994:68.